Bristol-Myers Squibb
BMY
$65.48
Share price
-0.76%
Change (1 day)
-12.98%
Change (1 year)
Categories
EPS for Bristol-Myers Squibb (BMY)
EPS in 2023 (TTM): $3.46
According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is $3.46. In 2022 the company made an earnings per share (EPS) of $2.98 a decrease over its 2021 EPS that were of $3.17.
EPS history for Bristol-Myers Squibb from 2012 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $3.46 | 16.11% |
| 2022 | $2.98 | -6.04% |
| 2021 | $3.17 | -179.29% |
| 2020 | -$4.00 | -281.37% |
| 2019 | $2.21 | -27.21% |
| 2018 | $3.03 | |
| 2016 | $2.67 | 175.26% |
| 2015 | $0.97 | -19.83% |
| 2014 | $1.21 | -22.44% |
| 2013 | $1.56 | 34.48% |
| 2012 | $1.16 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $4.84 | 39.92% | 🇺🇸 USA |
 Novartis NVS | $3.28 | -5.20% | 🇨🇭 Switzerland |
 Pfizer PFE | $5.18 | 49.71% | 🇺🇸 USA |
 AbbVie ABBV | $4.27 | 23.51% | 🇺🇸 USA |
 Eli Lilly LLY | $6.82 | 97.09% | 🇺🇸 USA |
 Amgen AMGN | $14.81 | 328.03% | 🇺🇸 USA |
 Sanofi SNY | $2.85 | -17.77% | 🇫🇷 France |
 Biogen BIIB | $21.62 | 524.86% | 🇺🇸 USA |
 Merck MRK | $5.73 | 65.61% | 🇺🇸 USA |
 AstraZeneca AZN | $1.52 | -56.21% | 🇬🇧 UK |